High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.

Blood
Arnaud JaccardJean-Paul Fermand

Abstract

We treated 5 patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome and multifocal bone lesions or diffuse bone marrow plasmacytic infiltration with high-dose therapy (HDT) and autologous blood stem cell transplantation. In all cases, the treatment produced remission of plasma cell proliferation associated with marked improvement in the patients' performance status, neurologic symptoms, and other manifestations of the syndrome. HDT with stem cell support should be investigated further as a therapeutic option in patients with POEMS syndrome and disseminated plasma cell dyscrasia.

References

Dec 31, 1992·The New England Journal of Medicine·G D MirallesN J Talley
May 1, 1987·British Journal of Haematology·P J SelbyJ S Malpas
Jul 1, 1981·British Journal of Haematology·M C DelaucheM Seligmann
Feb 1, 1983·Neurology·J J KellyP J Dyck
Jun 1, 1984·Neurology·T NakanishiY Ozaki
Apr 1, 1995·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·A B Subrahmanyam, A V Mehta
Dec 1, 1994·The American Journal of Medicine·M J SoubrierB J Sauvezie
Jun 1, 1996·Blood Reviews·S Schey
Oct 21, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Y NakamotoA B Miura
Dec 2, 2000·Bone Marrow Transplantation·M A GertzM R Litzow

❮ Previous
Next ❯

Citations

Apr 30, 2004·Current Treatment Options in Oncology·Angela Dispenzieri, Morie A Gertz
May 10, 2011·International Journal of Hematology·Motohiro ShindoYutaka Kohgo
Dec 2, 2008·Nature Clinical Practice. Neurology·Alain CréangeAline Santin
Mar 6, 2003·Reviews in Clinical and Experimental Hematology·Robert A Kyle, S Vincent Rajkumar
Sep 1, 2005·Journal of Clinical Neuromuscular Disease·Preeti SahotaDheeraj Khurana
May 25, 2013·Journal of Clinical Neuromuscular Disease·Simin Mansoor, Tulio E Bertorini
Sep 20, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·M Vermeulen, M H J van Oers
Jul 2, 2011·Internal Medicine·Kazumoto ShibuyaSatoshi Kuwabara
Nov 24, 2004·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Ilija TomićVlado Cvijanović
Dec 19, 2013·Case Reports in Oncological Medicine·S HaiderN Abdel Karim
Sep 7, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Nizar ChahinP James B Dyck
Sep 23, 2008·Revue neurologique·M A RafaiI Slassi
Oct 8, 2011·Clinical and Experimental Nephrology·Atsuko Y HigashiAtsushi Fukatsu
Jun 17, 2011·Current Opinion in Neurology·Marina Scarlato, Stefano C Previtali
Jun 15, 2005·Expert Opinion on Pharmacotherapy·Angela Dispenzieri, Morie A Gertz
Nov 29, 2014·Radiation Oncology·Yang-Gun SuhJaeho Cho
Jul 17, 2007·La Presse médicale·Martin Soubrier
Sep 14, 2007·Blood Reviews·Angela Dispenzieri
Jun 19, 2007·Addictive Behaviors·Brian BorsariChristopher W Kahler
Feb 13, 2007·Micron : the International Research and Review Journal for Microscopy·J M VallatP Couratier
Mar 28, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Satoru SanadaMasayuki Suzuki
Jun 28, 2005·American Journal of Hematology·Apar Kishor GantiStefano Tarantolo
Jul 13, 2005·Acta Neurologica Scandinavica·J Finsterer
Jul 9, 2003·Immunological Reviews·Robert A Kyle, S Vincent Rajkumar
Apr 29, 2004·American Journal of Hematology·Marjatta SinisaloOle Wirta
Jan 29, 2008·European Journal of Haematology·Angela DispenzieriMorie A Gertz
Feb 13, 2013·British Journal of Haematology·Jian Li, Dao-bin Zhou
Jun 18, 2011·American Journal of Hematology·Angela Dispenzieri
Jun 26, 2012·The Journal of Dermatology·Minoru HasegawaKazuhiko Takehara
Jul 19, 2012·American Journal of Hematology·Angela Dispenzieri
Feb 18, 2014·American Journal of Hematology·Angela Dispenzieri
Sep 4, 2015·American Journal of Hematology·Angela Dispenzieri
Jun 20, 2006·Journal of the American Academy of Dermatology·Julie A PhillipsJeffrey P Callen
Jul 4, 2007·Hematology·Sachin GuptaHarinder S Juneja
Jan 28, 2014·Clinical Lymphoma, Myeloma & Leukemia·Chiaki Nakaseko
May 2, 2012·Blood·Angela Dispenzieri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.